dc.contributor.author | Chilakamarri, Geetha | eng |
dc.contributor.author | Weismantel, David | eng |
dc.contributor.author | Weismantel, Arlene McFarlin | eng |
dc.date.issued | 2009 | eng |
dc.description.abstract | lithium, triiodothyronine (T3), and atypical antipsychotics are all effective adjuncts. Lithium (serum levels >0.5 mEq/L) can produce clinical improvement when added to ineffective antidepressant treatment (strength of recommendation [SOR]: A, meta-analysis of randomized controlled trials [RCTs]). Thyroid supplementation using T3 at doses no higher than 50 mcg per day also increases the effectiveness of antidepressant therapy (SOR: B, meta- analysis of RCT and cohort studies). Atypical antipsychotic agents are less effective adjuncts for patients with treatment-resistant major depressive disorder (SOR: B, meta-analysis of RCT and cohort studies). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3862 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2009 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 58, no. 10 (October 2009): 550-551. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | thyroid supplementation | eng |
dc.subject | Sequenced Treatment Alternatives to Relieve Depression (STAR*D) | eng |
dc.subject | atypical antipsychotic agents | eng |
dc.subject.lcsh | Antidepressants | eng |
dc.subject.lcsh | Antipsychotic drugs | eng |
dc.subject.lcsh | Lithium -- Therapeutic use | eng |
dc.subject.lcsh | Triiodothyronine -- Therapeutic use | eng |
dc.title | Can nonantidepressants help treat depression? | eng |
dc.type | Article | eng |